title: A timely reminder about the concomitant use of fusidic acid with statins.
authors.forename: Raquel
authors.initials: R
authors.lastname: Cowan
authors.forename: Paul D R
authors.initials: PD
authors.lastname: Johnson
authors.forename: Karen
authors.initials: K
authors.lastname: Urbancic
authors.forename: M Lindsay
authors.initials: ML
authors.lastname: Grayson
mesh_terms: D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004347:Drug Interactions; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005464:Fluorobenzenes / Q000009:adverse effects / Q000627:therapeutic use*; D005672:Fusidic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D010003:Osteoarthritis / Q000188:drug therapy; D016459:Prosthesis-Related Infections / Q000188:drug therapy; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D000068718:Rosuvastatin Calcium; D013203:Staphylococcal Infections / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D005672:Fusidic Acid; D000068718:Rosuvastatin Calcium